JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged)
WKN A2PR31 | ISIN LU2053353749 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU0208607159 | Pictet - Biotech - P dy USD | +66,89 % | +22,59 % | 2,85 |
|
| 2 | LU0320646986 | Pictet - Biotech - P dy GBP | +65,15 % | +22,73 % | 2,75 |
|
| 3 | LU0108459552 | Candriam Equities L Biotechnology, C - Distribution | +60,32 % | +22,07 % | 2,62 |
|
| 4 | LU2053352774 | JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - USD | +51,40 % | +20,83 % | 2,35 |
|
| 5 | LU2053352691 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - USD | +50,55 % | +20,83 % | 2,30 |
|
| 12 | LU2053353749 | JPMorgan Funds - Thematics - Genetic Therapies C2 (dist) - CHF (hedged) | +46,37 % | +20,58 % | 2,13 |
|
| 13 | LU2053353665 | JPMorgan Funds - Thematics - Genetic Therapies A (dist) - CHF (hedged) | +45,55 % | +20,57 % | 2,09 |
|
| 14 | AT0000746748 | ERSTE STOCK BIOTEC EUR R01 (A) | +42,91 % | +19,53 % | 2,07 |
|
| 15 | DE000A2DU172 | Allianz Biotechnologie - P - EUR | +43,78 % | +21,24 % | 1,94 |
|
| 16 | DE000A2AMPU5 | Allianz Biotechnologie - R - EUR | +43,62 % | +21,24 % | 1,93 |
|
| 17 | DE0008481862 | Allianz Biotechnologie - A - EUR | +42,38 % | +21,24 % | 1,87 |
|